NGNE · Neurogene Inc. · Share Buybacks
$22.15
-0.78 (-3.40%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$458.53M
Shares
20.70M
Volume · Nov 20
178.27K
Avg daily vol (3M)
308.44K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-08-11 | — | $150,000,000 | $86,200,000 as of 2026-09-30 | — | 10-Q , filed 2026-11-09 |
Key facts
CIK
1404644
CUSIP
64135M105
13F (30d)
128 filings
122 filers
Visit website
Investor relations